Concepedia

Author

Jonathan Cebon

Ludwig Cancer ResearchORCID

Also Known As

Australasian Gastro-Intestinal Trials Group (AGITG) AG0001H Investigators, Cebon, J, Cebon, Jonathan, H Vaughan, Ivana Cataldo, J Cebon, J S Cebon, J. CEBON, J. Cebon, J. S. Cebon

555

Publications

44.4K

Citations

88

H-Index

143

Concepts

All Affiliations

Ludwig Cancer ResearchAustin HealthOlivia Newton-John Cancer Wellness & Research CentreThe University of MelbourneLa Trobe University
JC

About

Jonathan Cebon is an author at Ludwig Cancer Research specializing in medicine, immunology, and immunotherapy.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

38

79

9.6K

2

Health Sciences

12

12

728

3

Allergy

10

10

1.2K

4

Engineering

4

4

248

5

Natural Sciences

2

2

70

Jonathan Cebon

×

212

Publications

33.5K

Citations

79

H-Index

YearCitations

Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma

Jedd D. Wolchok, Vanna Chiarion‐Sileni, René González,

New England Journal of Medicine

2017

5.3K

Pan-cancer analysis of whole genomes

Lauri A. Aaltonen, Federico Abascal, Adam Abeshouse,

Nature

2020

3.1K

Combined BRAF and MEK Inhibition in Melanoma with BRAF V600 Mutations

Keith T. Flaherty, J. Infante, Adil Daud,

New England Journal of Medicine

2012

2.8K

Oncolytic Virotherapy Promotes Intratumoral T Cell Infiltration and Improves Anti-PD-1 Immunotherapy

Antoni Ribas, Reinhard Dummer, Igor Puzanov,

Cell

2017

1.4K

Whole-genome landscapes of major melanoma subtypes

Nicholas K. Hayward, James S. Wilmott, Nicola Waddell,

Nature

2017

1.4K

Randomized Phase III Study of Temozolomide Versus Dacarbazine in the Treatment of Patients With Advanced Metastatic Malignant Melanoma

Mark R. Middleton, Jean‐Jacques Grob, Neil K. Aaronson,

Journal of Clinical Oncology

2000

1.3K

CMTM6 maintains the expression of PD-L1 and regulates anti-tumour immunity

Marian L. Burr, Christina E. Sparbier, Yih-Chih Chan,

Nature

2017

910

Granulocyte/macrophage colony-stimulating factor-deficient mice show no major perturbation of hematopoiesis but develop a characteristic pulmonary pathology.

Edouard G. Stanley, Graham J. Lieschke, D Grail,

Proceedings of the National Academy of Sciences

1994

873

Type I IFNs Enhance the Terminal Differentiation of Dendritic Cells

Thomas Luft, Ken C. Pang, E. W. Prosser Thomas,

The Journal of Immunology

1998

604

Comprehensive molecular characterization of mitochondrial genomes in human cancers

Yuan Yuan, Young Seok Ju, Young-Wook Kim,

Nature Genetics

2020

489

Page 1